ID
12862
Beschrijving
A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056); ODM derived from: https://clinicaltrials.gov/show/NCT00473889
Link
https://clinicaltrials.gov/show/NCT00473889
Trefwoorden
Versies (1)
- 03-01-16 03-01-16 -
Geüploaded op
3 januari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889
Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
investigational agents
Datatype
boolean
Alias
- UMLS CUI [1]
- C1875319
Beschrijving
pregnancy; lactating
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Beschrijving
hiv positive
Datatype
boolean
Alias
- UMLS CUI [1]
- C0019699
Beschrijving
hepatitis
Datatype
boolean
Alias
- UMLS CUI [1]
- C0019158
Beschrijving
Oral Route of Drug administration
Datatype
boolean
Alias
- UMLS CUI [1]
- C1527415
Beschrijving
brain cancer
Datatype
boolean
Alias
- UMLS CUI [1]
- C0153633
Beschrijving
bevacizumab
Datatype
boolean
Alias
- UMLS CUI [1]
- C0796392
Similar models
Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889
- StudyEvent: Eligibility
C0007131 (UMLS CUI [2])
C0205373 (UMLS CUI [1,2])
C0242379 (UMLS CUI [1,3])
C0205411 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0851346 (UMLS CUI [2])
C0006147 (UMLS CUI [1,2])